669-02-001 ISMRM Abstract

Cerebral blood flow alteration and its association with host gene in long-COVID patients: A transcriptomic-neuroimaging study

Primary: Neuro - Infectious Disease

Secondary: Contrast Mechanisms - Arterial Spin Labelling

669-02-001 · Neuroimaging Biomarkers Across the Spectrum of Brain Disorders · Thursday, 14 May, 9:25 AM–10:20 AM · Digital Posters Row J

Keywords: Brain COVID-19 Infectious disease Arterial spin labeling

Accepted

Yao Wang ¹, Jiankun Dai², Fuqing Zhou³

¹Department of radiology, Shandong Cancer Hospital, Jinan, Shandong, China

²MR Research, Beijing, China

³Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Presenting Author: Yao Wang

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Wulf Hanson S, Abbafati C, Aerts JG, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022; 328: 1604–1615. doi:10.1001/jama.2022.18931. [doi]

2. Wirth KJ, Scheibenbogen C and Paul F. An attempt to explain the neurological symptoms of myalgic encephalomyelitis/ chronic fatigue syndrome. J Transl Med 2021; 19: 471.doi:10.1186/s12967-021-03143-3. [doi]

3. Ajčević M, Iscra K, Furlanis G, et al. Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci Rep 2023;13: 5808. doi:10.1038/s41598-023-32275-3. [doi]

4. Initiative C-HG. Mapping the human genetic architecture of COVID-19. Nature 2021; 600: 472–477. doi:10.1038/s41586-021-03767-x. [doi]

5. Zhu D, Zhao R, Yuan H, et al. Host genetic factors, comorbidities and the risk of severe COVID-19.J Epidemiol Glob Health 2023; 13: 279–291.doi:10.1007/s44197-023-00106-3. [doi]

6. Arnatkeviciute A, Fulcher BD and Fornito A. A practical guide to linking brain-wide gene expression and neuroimaging data. NeuroImage 2019; 189: 353–367.doi: 10.1016/j.neuroimage.2019.01.011. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/669-02-001